PETRINI, IACOPO Statistiche
PETRINI, IACOPO
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
2009-01-01 Vasile, E.; Masi, G.; Fornaro, L.; Cupini, S.; Loupakis, F.; Bursi, S.; Petrini, Iacopo; DI DONATO, S.; Brunetti, I. M.; Ricci, S.; Antonuzzo, A.; Chiara, S.; Amoroso, D.; Andreuccetti, M.; Falcone, Alfredo
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
2020-01-01 Del Re, Marzia; Cucchiara, Federico; Rofi, Eleonora; Fontanelli, Lorenzo; Petrini, Iacopo; Gri, Nicole; Pasquini, Giulia; Rizzo, Mimma; Gabelloni, Michela; Belluomini, Lorenzo; Crucitta, Stefania; Ciampi, Raffaele; Frassoldati, Antonio; Neri, Emanuele; Porta, Camillo; Danesi, Romano
A phase II (PhII) trial of sorafenib (S) in combination with 5-fluorouracil (5FU) continuous infusion (c.i.) in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary data.
2009-01-01 Petrini, Iacopo; Lencioni, M; Ricasoli, M; Iannopollo, M; Orlandini, C; Oliveri, F; Filipponi, Franco; Bartolozzi, Carlo; DEL TACCA, Mario; Ricci, S.
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
2014-01-01 Petrini, Iacopo; Meltzer, Ps; Kim, Ik; Lucchi, Marco; Park, Ks; Fontanini, Gabriella; Gao, J; Zucali, Pa; Calabrese, F; Favaretto, A; Rea, F; Rodriguez Canales, J; Walker, Rl; Pineda, M; Zhu, Yj; Lau, C; Killian, Kj; Bilke, S; Voeller, D; Dakshanamurthy, S; Wang, Y; Giaccone, G.
Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells
2014-01-01 Pacini, Simone; Petrini, Iacopo
Array Comparative Genomic Hybridization analysis of resected thymomas on paraffin embedded material
2009-01-01 Petrini, Iacopo; Zuccali, P. A; Meltzer, P; Killian, K; Di Tommaso, L; Incarbone, M; Suuriniemi, M; Merino, M; Wang, Y; Santoro, A; Giaccone, G.
Array comparative genomic hybridization of thymic epithelial tumors identifies loss of CDKN2A as a prognostic factor and BCL2 family members as targets for therapy
2011-01-01 Petrini, Iacopo; Zucali, P. A; Lee, Hs; Luo, J; Killian, K. J; Melzer, P. S; Wang, Y; Giaccone, G.
Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer.
2011-01-01 Jih Hsiang, Lee; Petrini, Iacopo; Jin Hyeok, Hwang; Giovannetti, Elisa; Johannes, Voortman; Yonghong, Wang; Seth M, Steinberg; Paul S, Meltzer; Yisong, Wang; Giuseppe, Giaccone
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
2012-01-01 Galimberti, Sara; Guerrini, Francesca; Salvi, F; Petrini, Iacopo; Gioia, D; Messa, E; Palumbo, Ga; Cilloni, D; Petrini, Mario; Levis, A.
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC
2014-01-01 DEL RE, Marzia; Landi, L; Tiseo, M; Camerini, A; Petrini, Iacopo; Inno, A; Citi, V; Salvini, J; Minuti, Gabriele; Vasile, E; Falcone, Alfredo; Gori, S; Amoroso, D; Ardizzoni, A; Cappuzzo, F; Danesi, Romano
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)
2018-01-01 Imbimbo, Martina; Ottaviano, Margaret; Vitali, Milena; Fabbri, Alessandra; Leuzzi, Giovanni; Fiore, Michele; Franceschini, Davide; Pasello, Giulia; Perrino, Matteo; Schiavon, Marco; Pruneri, Giancarlo; Dei Tos, Angelo Paolo; Sangalli, Claudia; Garassino, Marina Chiara; Berardi, Rossana; Alessi, Alessandra; Calareso, Giuseppina; Petrini, Iacopo; Scorsetti, Marta; Scotti, Vieri; Rosso, Lorenzo; Rea, Federico; Pastorino, Ugo; Casali, Paolo Giovanni; Ramella, Sara; Ricardi, Umberto; Abate-Daga, Laura; Torri, Valter; Trama, Annalisa; Palmieri, Giovannella; Marino, Mirella; Zucali, Paolo Andrea
Biology of MET: a double life between normal tissue repair and tumor progression
2015-01-01 Petrini, Iacopo
Capecitabine ( C ), in combination with irinotecan ( I ) and oxaliplatin ( O ) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.)
2007-01-01 Bursi, S.; Masi, G.; Loupakis, F.; Antonuzzo, A.; Chiara, S.; Pfanner, E.; Petrini, Iacopo; Barletta, M. T.; Baldi, G. G.; Falcone, Alfredo
Capecitabine (C) in combination with Irinotecan (I) and Oxaliplatin (O) (XELOXIRI) in patients with metastatic colorectal cancer (MCRC): preliminary results of a pilot study by Gruppo Oncologico Nord Ovest (G.O.N.O.)
2006-01-01 Bursi, S.; Masi, G.; Antonuzzo, A.; Cerri, E.; Loupakis, F.; Barbara, C.; Barletta, M.; Allegrini, G.; Cupini, S.; Ricci, S.; Brunetti, I.; Pfanner, E.; Lencioni, M.; Murr, R.; Petrini, Iacopo; Tognarini, L.; Andreuccetti, M.; Falcone, Alfredo
CD57 and γδ T‐cell receptor expression in nodal metastatic spread of melanoma
2012-01-01 Petrini, Iacopo; Scatena, C; Naccarato, ANTONIO GIUSEPPE; Petrini, Mario
Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment
2019-01-01 Re, M. D.; Addeo, A.; Passaro, A.; Petrini, I.; Van Schaik, R. H. N.; Danesi, R.
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
2021-01-01 Conforti, F.; Marino, M.; Vitolo, V.; Spaggiari, L.; Mantegazza, R.; Zucali, P.; Ruffini, E.; di Tommaso, L.; Pelosi, G.; Barberis, M.; Petrini, I.; Palmieri, G.; Pasello, G.; Galli, G.; Berardi, R.; Garassino, M.; Filosso, P.; Alloisio, M.; Scorsetti, M.; Orecchia, R.; Pala, L.; Abatedaga, L.; Cinieri, S.; De Pas, T.
CLONOTYPE AND MUTATIONAL PATTERN IN TCRGD LARGE GRANULAR LYMPHOCYTE LEUKEMIA
2017-01-01 Teramo, A; Ciabatti, E; Tarrini, G; Petrini, I; Barila, G; Calabretto, G; Vicenzetto, C; Leoncin, M; Ercolin, C; Cabrelle, A; Galimberti, S; Grossi, R; Pisanti, N; Semenzato, G; Zambello, R
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives
2021-01-01 Cucchiara, F.; Petrini, I.; Romei, C.; Crucitta, S.; Lucchesi, M.; Valleggi, S.; Scavone, C.; Capuano, A.; De Liperi, A.; Chella, A.; Danesi, R.; Del Re, M.
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
2023-01-01 Crucitta, Stefania; Ruglioni, Martina; Novi, Claudia; Manganiello, Mascia; Arici, Roberta; Petrini, Iacopo; Pardini, Eleonora; Cucchiara, Federico; Marmorino, Federica; Cremolini, Chiara; Fogli, Stefano; Danesi, Romano; Del Re, Marzia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer | 1-gen-2009 | Vasile, E.; Masi, G.; Fornaro, L.; Cupini, S.; Loupakis, F.; Bursi, S.; Petrini, Iacopo; DI DONATO, S.; Brunetti, I. M.; Ricci, S.; Antonuzzo, A.; Chiara, S.; Amoroso, D.; Andreuccetti, M.; Falcone, Alfredo | |
| A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC | 1-gen-2020 | Del Re, Marzia; Cucchiara, Federico; Rofi, Eleonora; Fontanelli, Lorenzo; Petrini, Iacopo; Gri, Nicole; Pasquini, Giulia; Rizzo, Mimma; Gabelloni, Michela; Belluomini, Lorenzo; Crucitta, Stefania; Ciampi, Raffaele; Frassoldati, Antonio; Neri, Emanuele; Porta, Camillo; Danesi, Romano | |
| A phase II (PhII) trial of sorafenib (S) in combination with 5-fluorouracil (5FU) continuous infusion (c.i.) in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary data. | 1-gen-2009 | Petrini, Iacopo; Lencioni, M; Ricasoli, M; Iannopollo, M; Orlandini, C; Oliveri, F; Filipponi, Franco; Bartolozzi, Carlo; DEL TACCA, Mario; Ricci, S. | |
| A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. | 1-gen-2014 | Petrini, Iacopo; Meltzer, Ps; Kim, Ik; Lucchi, Marco; Park, Ks; Fontanini, Gabriella; Gao, J; Zucali, Pa; Calabrese, F; Favaretto, A; Rea, F; Rodriguez Canales, J; Walker, Rl; Pineda, M; Zhu, Yj; Lau, C; Killian, Kj; Bilke, S; Voeller, D; Dakshanamurthy, S; Wang, Y; Giaccone, G. | |
| Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells | 1-gen-2014 | Pacini, Simone; Petrini, Iacopo | |
| Array Comparative Genomic Hybridization analysis of resected thymomas on paraffin embedded material | 1-gen-2009 | Petrini, Iacopo; Zuccali, P. A; Meltzer, P; Killian, K; Di Tommaso, L; Incarbone, M; Suuriniemi, M; Merino, M; Wang, Y; Santoro, A; Giaccone, G. | |
| Array comparative genomic hybridization of thymic epithelial tumors identifies loss of CDKN2A as a prognostic factor and BCL2 family members as targets for therapy | 1-gen-2011 | Petrini, Iacopo; Zucali, P. A; Lee, Hs; Luo, J; Killian, K. J; Melzer, P. S; Wang, Y; Giaccone, G. | |
| Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer. | 1-gen-2011 | Jih Hsiang, Lee; Petrini, Iacopo; Jin Hyeok, Hwang; Giovannetti, Elisa; Johannes, Voortman; Yonghong, Wang; Seth M, Steinberg; Paul S, Meltzer; Yisong, Wang; Giuseppe, Giaccone | |
| Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. | 1-gen-2012 | Galimberti, Sara; Guerrini, Francesca; Salvi, F; Petrini, Iacopo; Gioia, D; Messa, E; Palumbo, Ga; Cilloni, D; Petrini, Mario; Levis, A. | |
| Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC | 1-gen-2014 | DEL RE, Marzia; Landi, L; Tiseo, M; Camerini, A; Petrini, Iacopo; Inno, A; Citi, V; Salvini, J; Minuti, Gabriele; Vasile, E; Falcone, Alfredo; Gori, S; Amoroso, D; Ardizzoni, A; Cappuzzo, F; Danesi, Romano | |
| Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) | 1-gen-2018 | Imbimbo, Martina; Ottaviano, Margaret; Vitali, Milena; Fabbri, Alessandra; Leuzzi, Giovanni; Fiore, Michele; Franceschini, Davide; Pasello, Giulia; Perrino, Matteo; Schiavon, Marco; Pruneri, Giancarlo; Dei Tos, Angelo Paolo; Sangalli, Claudia; Garassino, Marina Chiara; Berardi, Rossana; Alessi, Alessandra; Calareso, Giuseppina; Petrini, Iacopo; Scorsetti, Marta; Scotti, Vieri; Rosso, Lorenzo; Rea, Federico; Pastorino, Ugo; Casali, Paolo Giovanni; Ramella, Sara; Ricardi, Umberto; Abate-Daga, Laura; Torri, Valter; Trama, Annalisa; Palmieri, Giovannella; Marino, Mirella; Zucali, Paolo Andrea | |
| Biology of MET: a double life between normal tissue repair and tumor progression | 1-gen-2015 | Petrini, Iacopo | |
| Capecitabine ( C ), in combination with irinotecan ( I ) and oxaliplatin ( O ) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.) | 1-gen-2007 | Bursi, S.; Masi, G.; Loupakis, F.; Antonuzzo, A.; Chiara, S.; Pfanner, E.; Petrini, Iacopo; Barletta, M. T.; Baldi, G. G.; Falcone, Alfredo | |
| Capecitabine (C) in combination with Irinotecan (I) and Oxaliplatin (O) (XELOXIRI) in patients with metastatic colorectal cancer (MCRC): preliminary results of a pilot study by Gruppo Oncologico Nord Ovest (G.O.N.O.) | 1-gen-2006 | Bursi, S.; Masi, G.; Antonuzzo, A.; Cerri, E.; Loupakis, F.; Barbara, C.; Barletta, M.; Allegrini, G.; Cupini, S.; Ricci, S.; Brunetti, I.; Pfanner, E.; Lencioni, M.; Murr, R.; Petrini, Iacopo; Tognarini, L.; Andreuccetti, M.; Falcone, Alfredo | |
| CD57 and γδ T‐cell receptor expression in nodal metastatic spread of melanoma | 1-gen-2012 | Petrini, Iacopo; Scatena, C; Naccarato, ANTONIO GIUSEPPE; Petrini, Mario | |
| Circulating tumor DNA and the future of EGFR-mutant lung cancer treatment | 1-gen-2019 | Re, M. D.; Addeo, A.; Passaro, A.; Petrini, I.; Van Schaik, R. H. N.; Danesi, R. | |
| Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM) | 1-gen-2021 | Conforti, F.; Marino, M.; Vitolo, V.; Spaggiari, L.; Mantegazza, R.; Zucali, P.; Ruffini, E.; di Tommaso, L.; Pelosi, G.; Barberis, M.; Petrini, I.; Palmieri, G.; Pasello, G.; Galli, G.; Berardi, R.; Garassino, M.; Filosso, P.; Alloisio, M.; Scorsetti, M.; Orecchia, R.; Pala, L.; Abatedaga, L.; Cinieri, S.; De Pas, T. | |
| CLONOTYPE AND MUTATIONAL PATTERN IN TCRGD LARGE GRANULAR LYMPHOCYTE LEUKEMIA | 1-gen-2017 | Teramo, A; Ciabatti, E; Tarrini, G; Petrini, I; Barila, G; Calabretto, G; Vicenzetto, C; Leoncin, M; Ercolin, C; Cabrelle, A; Galimberti, S; Grossi, R; Pisanti, N; Semenzato, G; Zambello, R | |
| Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives | 1-gen-2021 | Cucchiara, F.; Petrini, I.; Romei, C.; Crucitta, S.; Lucchesi, M.; Valleggi, S.; Scavone, C.; Capuano, A.; De Liperi, A.; Chella, A.; Danesi, R.; Del Re, M. | |
| Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer | 1-gen-2023 | Crucitta, Stefania; Ruglioni, Martina; Novi, Claudia; Manganiello, Mascia; Arici, Roberta; Petrini, Iacopo; Pardini, Eleonora; Cucchiara, Federico; Marmorino, Federica; Cremolini, Chiara; Fogli, Stefano; Danesi, Romano; Del Re, Marzia |